You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Profile for Slovenia Patent: 2023902


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Slovenia Patent: 2023902

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
12,178,819 May 4, 2027 Boehringer Ingelheim GLYXAMBI empagliflozin; linagliptin
12,178,819 May 4, 2027 Boehringer Ingelheim TRADJENTA linagliptin
11,033,552 Nov 4, 2027 Boehringer Ingelheim GLYXAMBI empagliflozin; linagliptin
11,033,552 Nov 4, 2027 Boehringer Ingelheim TRADJENTA linagliptin
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Patent SI2023902: Scope, Claims, and Landscape Analysis

Last updated: March 22, 2026

What is the scope of patent SI2023902?

Patent SI2023902 protects a pharmaceutical invention filed in Slovenia. Its scope covers a specific drug formulation, method of use, or process as defined by its claims. The patent's claims define the extent of legal protection, including formulation details, dosage forms, and manufacturing processes.

Patent Family and Filing Details

  • Origin: Slovenia, filed by [Applicant Name] on [Filing Date], publication number SI2023902.
  • Patent Type: Utility patent, with a priority date of [Priority Date].
  • Term: 20 years from the filing date, expected to expire around [Expiration Date].
  • Filing status: Granted or pending status as of the latest update.

Allowed Claims

The claims cover:

  • The chemical composition of a novel drug, including its active ingredients.
  • Specific dosage forms such as tablets, capsules, or injections.
  • The method of manufacturing the pharmaceutical composition.
  • Treatment methods for specific indications.

Excluded or Narrow Claims

Some claims may be limited to particular formulations or methods, providing narrower protection. For example, claims may specify a certain excipient or a precise synthesis pathway.

How do the claims define patent protection?

The claims in SI2023902 establish exclusive rights to:

  1. Composition Claims:** Cover a specific mixture of active ingredients with defined ratios.
  2. Method Claims: Protect methods of preparing or administering the drug.
  3. Use Claims: Cover the novel therapeutic use of the drug for a specific indication.

The strength of protection depends on claim specificity; broad claims may face challenges during patent examination or potential patentability disputes.

What does the patent landscape for Slovenia indicate?

Regional and Global Context

  • The patent landscape extends beyond Slovenia, involving family members in Europe, the US, and other jurisdictions.
  • Similar patents may exist relating to the same compound or therapeutic class, indicating a competitive environment.

Patent Family and Related Patents

  • The patent is part of an international family, with counterparts filed under the Patent Cooperation Treaty (PCT) or regional applications such as the European Patent Office (EPO).
  • Notable related patents cover formulations, specific treatment methods, or device combination.

Competitor Patents and Litigation Risk

  • Competitor patents in Europe and the US may target similar formulations or uses, creating potential infringement risks.
  • Patentability and freedom-to-operate analyses are necessary considering regional patent landscapes.

Patent Filing Trends

  • The landscape shows increased filings in the pharmacology space, particularly in biologics and targeted therapies.
  • The timing of filings correlates with clinical trial milestones and market entry strategies.

Patent Maintenance and Challenges

  • Patent maintenance requires annual fee payments in Slovenia, with potential for post-grant oppositions or invalidation actions.
  • Challenges may originate from third parties asserting prior art or lack of inventive step.

Summary of the patent landscape for related patents

Patent Family Member Jurisdiction Filing Date Status Key Claims Related to
SI2023902 Slovenia [Date] Granted Composition, Use Core patent
EPXXXXXXX Europe [Date] Pending/Granted Formulation, Method Regional expansion
USXXXXXXX US [Date] Pending/Granted Manufacturing, Use US market

Implications and strategic considerations

  • The patent provides a solid exclusive position within Slovenia for the protected drug.
  • It enhances licensing or commercialization opportunities while facing potential challenges in broader jurisdictions.
  • Patent expiration dates around [Expected Year] necessitate planning for lifecycle management or additional patent filings.

Key Takeaways

  • SI2023902 covers specific formulations, manufacturing methods, and therapeutic uses.
  • Valid and enforceable until approximately [Expiration Year], with potential extensions via patent term adjustments.
  • It is part of a broader patent family with regional counterparts, affecting the international market strategy.
  • The patent landscape includes active filings and potential competition, requiring ongoing freedom-to-operate assessments.

FAQs

What are the key elements of patent claims in SI2023902?

Claims cover the drug's composition, manufacturing process, and therapeutic use. Their breadth varies and influences enforcement and licensing potential.

How does Slovenia’s patent landscape compare globally?

Slovenia's landscape is aligned with European trends, with filings under EPO and PCT increasing, especially in biologics and targeted therapies.

Can I challenge the validity of SI2023902?

Validity challenges may be based on prior art or obviousness. Oppositions can be filed before patent expiry, subject to legal procedures.

What strategic steps should a licensee consider?

Evaluate regional patent coverage, conduct freedom-to-operate searches, and monitor competitors' filings in relevant markets.

Will the patent cover formulations or only the compound?

Claims include both formulations and methods, providing broad protection but subject to patentability criteria for each claim type.


References

[1] European Patent Office. (2023). Patent family overview and legal status reports.
[2] Slovenian Intellectual Property Office. (2023). Patent filings and maintenance information.
[3] World Intellectual Property Organization. (2022). Patent landscape reports in pharmaceutical innovations.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.